HK1114171A1 - Copeptin-based diagnostic kit for disorders - Google Patents

Copeptin-based diagnostic kit for disorders

Info

Publication number
HK1114171A1
HK1114171A1 HK08101167A HK08101167A HK1114171A1 HK 1114171 A1 HK1114171 A1 HK 1114171A1 HK 08101167 A HK08101167 A HK 08101167A HK 08101167 A HK08101167 A HK 08101167A HK 1114171 A1 HK1114171 A1 HK 1114171A1
Authority
HK
Hong Kong
Prior art keywords
copeptin
disorders
diagnostic kit
based diagnostic
kit
Prior art date
Application number
HK08101167A
Other languages
English (en)
Inventor
Andreas Bergmann
Joachim Struck
Original Assignee
Brahms Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brahms Ag filed Critical Brahms Ag
Publication of HK1114171A1 publication Critical patent/HK1114171A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5757—Vasoactive intestinal peptide [VIP] or related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/15—Oxytocin or vasopressin; related peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK08101167A 2004-08-19 2008-01-30 Copeptin-based diagnostic kit for disorders HK1114171A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20040019732 EP1628136A1 (en) 2004-08-19 2004-08-19 Method of diagnosis of disease using copeptin
PCT/EP2005/009001 WO2006018315A1 (en) 2004-08-19 2005-08-19 Diagnostic method for disorders using copeptin

Publications (1)

Publication Number Publication Date
HK1114171A1 true HK1114171A1 (en) 2008-10-24

Family

ID=34926232

Family Applications (2)

Application Number Title Priority Date Filing Date
HK08101167A HK1114171A1 (en) 2004-08-19 2008-01-30 Copeptin-based diagnostic kit for disorders
HK12113460.0A HK1172690A1 (zh) 2004-08-19 2012-12-27 基於 的試劑盒

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK12113460.0A HK1172690A1 (zh) 2004-08-19 2012-12-27 基於 的試劑盒

Country Status (11)

Country Link
US (3) US7807397B2 (zh)
EP (2) EP1628136A1 (zh)
JP (2) JP4932714B2 (zh)
CN (2) CN102539789B (zh)
AR (1) AR050215A1 (zh)
AT (1) ATE375518T1 (zh)
DE (1) DE602005002836T2 (zh)
ES (1) ES2296224T3 (zh)
HK (2) HK1114171A1 (zh)
MX (1) MXPA06014775A (zh)
WO (1) WO2006018315A1 (zh)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140046407A1 (en) * 2001-08-31 2014-02-13 Bio Control Medical (B.C.M.) Ltd. Nerve stimulation techniques
DE102006034142A1 (de) 2006-07-24 2008-01-31 B.R.A.H.M.S. Aktiengesellschaft Verfahren zur Steuerung der Therapie von Patienten mit Herzinsuffizienz anhand der vitro Bestimmung von Schwellenwerten von vasoaktiven Peptiden
DE102006046996A1 (de) * 2006-10-01 2008-04-03 Brahms Aktiengesellschaft Diagnose von Infektionen oder Entzündungserkrankungen der Atemwege und Lunge assoziiert mit Herzinsuffizienz
EP2544001A3 (en) * 2006-10-18 2013-04-24 Axela Inc. Measuring multiple analytes over a broad range of concentrations using optical diffraction
DE102006050497A1 (de) * 2006-10-26 2008-04-30 Brahms Aktiengesellschaft Risikostratifizierung des akuten Koronarsyndroms mittels Fragmenten / Teilpeptiden des proVasopressins, insbesondere Copeptin oder Neurophysin II
DE112007003185A5 (de) * 2006-10-26 2009-10-01 Brahms Aktiengesellschaft Risikostratifizierung des akuten Koronarsyndroms mittels Fragmenten / Teilpeptiden des proVasopressins, insbesondere Copeptin oder Neurophysin II
DE102006053442A1 (de) 2006-11-12 2008-05-15 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung von Infektionen und chronischen Erkrankungen der Atemwege und Lunge mittels proVasopressin, insbesondere Copeptin oder Neurophysin II
DE102006058266A1 (de) * 2006-12-08 2008-06-12 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung von Herzinsuffizienz mittels Neurophysin
EP2180322A1 (en) * 2008-10-22 2010-04-28 BRAHMS Aktiengesellschaft Prognostic biomarkers for the progression of primary chronic kidney disease
EP3199951B1 (en) * 2008-10-31 2019-11-20 B.R.A.H.M.S GmbH Arginine vasopressin pro-hormone as predicitive biomarker for diabetes
US20100312581A1 (en) * 2009-06-08 2010-12-09 Peter James Wachtell Process and system for efficient allocation of medical resources
WO2010146064A1 (en) 2009-06-16 2010-12-23 B.R.A.H.M.S Gmbh Diagnostical use of peroxiredoxin 4
EP2583103B1 (en) * 2010-06-18 2016-04-20 B.R.A.H.M.S GmbH Biomarkers for the prediction of incident cancer
ES2642712T3 (es) 2011-05-26 2017-11-17 Phoenix Pharmaceuticals, Inc. Péptidos de foenixina
EP2541252A1 (en) 2011-06-30 2013-01-02 B.R.A.H.M.S GmbH Method of obtaining a binder to prepro-vasopressin or fragments thereof
CA2854563A1 (en) 2011-11-11 2013-05-16 Woomera Therapeutics Provasopressin antagonists and uses thereof
GB201210686D0 (en) * 2012-06-15 2012-08-01 Holsboermaschmeyer Neurochemie Gmbh V1B receptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level
GB201310782D0 (en) 2013-06-17 2013-07-31 Max Planck Innovation Gmbh Method for predicting a treatment response to a CRHR1 antagonist and/or V1B antagonist in a patient with depressive and/or anxiety symptoms
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9375478B1 (en) 2015-01-30 2016-06-28 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
EP3256858B1 (en) 2015-02-10 2020-03-25 B.R.A.H.M.S GmbH Histone h4 peptide as a biomarker
EP3279667A1 (en) 2016-08-02 2018-02-07 Abbott Laboratories Cardiac troponin i and copeptin as biomarkers for short-term mortality in acute exacerbation of chronic obstructive pulmonary disease (aecopd)
CN109061140A (zh) * 2018-08-31 2018-12-21 广州华澳生物科技有限公司 一种和肽素免疫层析检测试剂卡及其制备方法
CN109679924A (zh) * 2018-12-25 2019-04-26 广州万孚生物技术股份有限公司 高亲和力抗人和肽素的单克隆抗体及其制备方法与应用
CN109596839A (zh) * 2018-12-25 2019-04-09 广州万孚生物技术股份有限公司 人和肽素快速定量检测方法与试剂盒
WO2020156988A1 (en) * 2019-01-28 2020-08-06 B.R.A.H.M.S Gmbh Method to predict treatment response in patients with nocturnal enuresis
CN111007270A (zh) * 2019-11-27 2020-04-14 迪瑞医疗科技股份有限公司 和肽素化学发光免疫检测试剂盒及其制备方法
CN113406339A (zh) * 2021-08-19 2021-09-17 山东康华生物医疗科技股份有限公司 一种干式免疫荧光定量法人和肽素（cpp）检测试剂盒

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413783B1 (en) * 1997-09-18 2002-07-02 Meso Scale Technologies, Llc Assay sonication apparatus and methodology
WO2002002621A2 (en) * 2000-06-30 2002-01-10 Zymogenetics, Inc. Mammalian secreted proteins
US20040253637A1 (en) * 2001-04-13 2004-12-16 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
CN1166953C (zh) * 2001-05-30 2004-09-15 上海晶泰生物技术有限公司 一步法多指标检测心肌梗塞的快速金标检测试剂盒
WO2003045418A1 (fr) * 2001-11-26 2003-06-05 Daiichi Suntory Pharma Co., Ltd. Compositions médicales pour absorption nasale
EP1539818B1 (en) * 2002-07-16 2010-12-15 Woomera Therapeutics, Inc. Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells
WO2004058055A2 (en) * 2002-12-24 2004-07-15 Biosite Incorporated Method and system for disease detection using marker combinations
DE112007003185A5 (de) * 2006-10-26 2009-10-01 Brahms Aktiengesellschaft Risikostratifizierung des akuten Koronarsyndroms mittels Fragmenten / Teilpeptiden des proVasopressins, insbesondere Copeptin oder Neurophysin II
DE102006053442A1 (de) * 2006-11-12 2008-05-15 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung von Infektionen und chronischen Erkrankungen der Atemwege und Lunge mittels proVasopressin, insbesondere Copeptin oder Neurophysin II
DE102006060112A1 (de) * 2006-12-20 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM
DE102007010834A1 (de) * 2007-03-03 2008-09-04 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung von Herzinsuffizienz für NYHA I Patienten

Also Published As

Publication number Publication date
WO2006018315A1 (en) 2006-02-23
US20110008911A1 (en) 2011-01-13
DE602005002836D1 (de) 2007-11-22
MXPA06014775A (es) 2007-03-23
US7807397B2 (en) 2010-10-05
EP1738178A1 (en) 2007-01-03
CN101010591B (zh) 2011-12-21
ATE375518T1 (de) 2007-10-15
AR050215A1 (es) 2006-10-04
DE602005002836T2 (de) 2008-07-31
EP1738178B1 (en) 2007-10-10
CN101010591A (zh) 2007-08-01
JP4932714B2 (ja) 2012-05-16
EP1628136A1 (en) 2006-02-22
JP2008510151A (ja) 2008-04-03
CN102539789A (zh) 2012-07-04
CN102539789B (zh) 2015-04-08
JP2011227095A (ja) 2011-11-10
HK1172690A1 (zh) 2013-04-26
US20090221009A1 (en) 2009-09-03
US20170242037A1 (en) 2017-08-24
ES2296224T3 (es) 2008-04-16

Similar Documents

Publication Publication Date Title
HK1114171A1 (en) Copeptin-based diagnostic kit for disorders
GB2418854B (en) Multiparticulates
HUE054365T2 (hu) Bór-ftalidok terápiás alkalmazásra
GB0426609D0 (en) Analysis
GB0401730D0 (en) Diagnosis method
IL177155A0 (en) Therapeutic combinations
GB0420112D0 (en) Polyurethanes
HK1112171A1 (zh) 燒灼組織用的裝置
GB0406271D0 (en) Diagnostic test
GB0400976D0 (en) Methods of diagnosis
GB2410799B (en) Fluid-gauging probes
GB0423652D0 (en) Kit
GB0419199D0 (en) Methods of diagnosis
GB0408684D0 (en) Diagnostic method
GB0420873D0 (en) Methods of diagnosis
GB0412041D0 (en) Diagnostic assays
AU2004900330A0 (en) Diagnostic Kit
ZA200410106B (en) Diagnostic procedures
GB0427966D0 (en) Test kit
GB0403102D0 (en) Multiparticulates
GB0427745D0 (en) Multiparticulates
GB0413454D0 (en) Multiparticulates
GB0412844D0 (en) Probe
GB0501934D0 (en) Ostomy kit
GB0417622D0 (en) Cleaning kit